Fig. 4From: Post-progression treatment in cancer randomized trials: a cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020« Ten percent» pre-specified rules to assess post-progression treatment in the control arm of randomized clinical trials. Legend: post-progression therapy is referring to systemic treatmentBack to article page